JP2014532726A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014532726A5 JP2014532726A5 JP2014540154A JP2014540154A JP2014532726A5 JP 2014532726 A5 JP2014532726 A5 JP 2014532726A5 JP 2014540154 A JP2014540154 A JP 2014540154A JP 2014540154 A JP2014540154 A JP 2014540154A JP 2014532726 A5 JP2014532726 A5 JP 2014532726A5
- Authority
- JP
- Japan
- Prior art keywords
- thio
- pyridin
- cyanonaphthalen
- acceptable salt
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161555450P | 2011-11-03 | 2011-11-03 | |
| US61/555,450 | 2011-11-03 | ||
| US201261616363P | 2012-03-27 | 2012-03-27 | |
| US61/616,363 | 2012-03-27 | ||
| PCT/US2012/063415 WO2013067425A1 (en) | 2011-11-03 | 2012-11-02 | 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014532726A JP2014532726A (ja) | 2014-12-08 |
| JP2014532726A5 true JP2014532726A5 (enExample) | 2015-12-24 |
| JP6025853B2 JP6025853B2 (ja) | 2016-11-16 |
Family
ID=47178362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540154A Expired - Fee Related JP6025853B2 (ja) | 2011-11-03 | 2012-11-02 | ３，４−二置換ピリジン化合物、その使用方法、および、該化合物を含む組成物 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10047050B2 (enExample) |
| EP (2) | EP2776028B1 (enExample) |
| JP (1) | JP6025853B2 (enExample) |
| KR (1) | KR101988066B1 (enExample) |
| CN (2) | CN104023723B (enExample) |
| AU (1) | AU2012332154B2 (enExample) |
| BR (1) | BR112014010495A2 (enExample) |
| CA (1) | CA2852490A1 (enExample) |
| DK (1) | DK2776028T3 (enExample) |
| EA (1) | EA026101B1 (enExample) |
| ES (1) | ES2704233T3 (enExample) |
| HU (1) | HUE040625T2 (enExample) |
| IL (1) | IL232105A (enExample) |
| MX (1) | MX352904B (enExample) |
| MY (1) | MY180138A (enExample) |
| PH (1) | PH12014500997A1 (enExample) |
| PL (1) | PL2776028T3 (enExample) |
| SG (1) | SG11201402016PA (enExample) |
| UA (1) | UA114304C2 (enExample) |
| WO (1) | WO2013067425A1 (enExample) |
| ZA (1) | ZA201402795B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR081930A1 (es) * | 2010-06-16 | 2012-10-31 | Ardea Biosciences Inc | Compuestos de tioacetato |
| EP2776028B1 (en) * | 2011-11-03 | 2018-10-17 | Ardea Biosciences, Inc. | 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same |
| CN105439946B (zh) * | 2014-08-13 | 2018-02-02 | 益方生物科技（上海）有限公司 | 羧酸化合物及其制备方法和用途 |
| CN104292124B (zh) * | 2014-09-27 | 2016-01-20 | 张远强 | 硝基苯基取代的萘环丁二酸酰胺衍生物、其制备方法及用途 |
| CN104311452B (zh) * | 2014-09-27 | 2016-01-06 | 张远强 | 腈基萘环的丁二酸酰胺衍生物、其制备方法及用途 |
| WO2017028762A1 (zh) * | 2015-08-14 | 2017-02-23 | 广东东阳光药业有限公司 | 一种萘环化合物的晶型 |
| SG11201804100UA (en) * | 2015-12-08 | 2018-06-28 | Ardea Biosciences Inc | Pharmaceutical composition comprising a potent inhibitor of urat1 |
| CN105884807A (zh) * | 2016-04-26 | 2016-08-24 | 昆药集团股份有限公司 | 硼酸频那醇酯衍生物的制备方法、硫代乙酸盐化合物的制备方法 |
| CN106117130A (zh) * | 2016-06-28 | 2016-11-16 | 昆药集团股份有限公司 | 一种2‑((3‑(4‑氰基萘‑1‑基)吡啶‑4‑基)硫基)‑2‑甲基丙酸的晶型及其制备方法和药物组合物 |
| CN114315705B (zh) * | 2020-09-29 | 2024-02-20 | 杭州中美华东制药有限公司 | 一类urat1抑制剂及其制备方法与用途 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6054310B2 (ja) | 1979-02-21 | 1985-11-29 | 三井東圧化学株式会社 | ピリダジン誘導体と農園芸用殺菌剤 |
| US4889868A (en) | 1984-12-20 | 1989-12-26 | Rorer Pharmaceutical Corporation | Bis-imidazolinoamino derivatives as antiallergy compounds |
| US5051442A (en) | 1990-04-25 | 1991-09-24 | Merrell Dow Pharmaceuticals Inc. | 3-indolyl thioacetate derivatives and NMDA receptor antagonistic use thereof |
| KR100221041B1 (ko) | 1990-11-30 | 1999-09-15 | 야스이 쇼사꾸 | 2-아릴티아졸 유도체 및 그의 약제학적 조성물 |
| US5405873A (en) | 1992-09-10 | 1995-04-11 | Banyu Pharmaceutical Co., Ltd. | Substituted acetamide derivatives |
| US5344651A (en) | 1993-07-23 | 1994-09-06 | The Procter & Gamble Company | Cyproterone acetate thioacetate |
| US5945425A (en) | 1994-04-29 | 1999-08-31 | G.D. Searle & Co. | Method of using (H+ /K+)ATPase inhibitors as antiviral agents |
| US6017925A (en) | 1997-01-17 | 2000-01-25 | Merck & Co., Inc. | Integrin antagonists |
| AU2001275085A1 (en) * | 2000-06-01 | 2001-12-11 | Guilford Pharmaceuticals Inc. | Methods, compounds and compositions for treating gout |
| GB0108339D0 (en) | 2001-04-03 | 2001-05-23 | Syngenta Participations Ag | Organics compounds |
| JP3824899B2 (ja) * | 2001-09-21 | 2006-09-20 | 株式会社ヒューマンセルシステムズ | 腎臓及び胎盤型尿酸トランスポーターとその遺伝子 |
| ATE528001T1 (de) | 2004-08-25 | 2011-10-15 | Ardea Biosciences Inc | S-triazolyl-alpha-mercaptoacetanilide als inhibitoren von hiv-umkehrtranskriptase |
| WO2007050087A1 (en) | 2004-08-25 | 2007-05-03 | Ardea Biosciences, Inc. | N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
| GB0422057D0 (en) | 2004-10-05 | 2004-11-03 | Astrazeneca Ab | Novel compounds |
| US20070099970A1 (en) | 2005-08-19 | 2007-05-03 | Mackerell Alexander | Immunomodulatory compounds that target and inhibit the pY'binding site of tyrosene kinase p56 LCK SH2 domain |
| EP2001897A2 (en) | 2006-03-22 | 2008-12-17 | Syndexa Pharmaceuticals Corporation | Compounds and methods for treatment of disorders associated with er stress |
| WO2008030618A1 (en) | 2006-09-07 | 2008-03-13 | Amgen Inc. | Benzo-fused compounds for use in treating metabolic disorders |
| EP1939181A1 (en) | 2006-12-27 | 2008-07-02 | sanofi-aventis | Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase |
| NZ595035A (en) | 2007-11-27 | 2012-11-30 | Ardea Biosciences Inc | Substituted diazole and triazole compounds and compositions and methods of use |
| JP5431457B2 (ja) * | 2008-04-30 | 2014-03-05 | ウェルスタット セラピューティクス コーポレイション | 尿酸を減少させるテトラゾール化合物 |
| US8173690B2 (en) | 2008-09-04 | 2012-05-08 | Ardea Biosciences, Inc. | Compounds, compositions and methods of using same for modulating uric acid levels |
| JP2012502049A (ja) | 2008-09-04 | 2012-01-26 | アルディア バイオサイエンス，インク． | 尿酸値を調節するための化合物、組成物及びそれを使用する方法。 |
| WO2010135536A2 (en) | 2009-05-20 | 2010-11-25 | Ardea Biosciences, Inc. | Methods of modulating uric acid levels |
| JP2012527475A (ja) | 2009-05-20 | 2012-11-08 | アルディア バイオサイエンス，インク． | 尿酸値を調節するための化合物、組成物及び方法 |
| US20110082120A1 (en) | 2009-10-05 | 2011-04-07 | Milne Jill C | Substituted thioacetic acid salicylate derivatives and their uses |
| SG182404A1 (en) | 2010-01-08 | 2012-08-30 | Ardea Biosciences Inc | Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof |
| US9402827B2 (en) * | 2010-03-30 | 2016-08-02 | Ardea Biosciences, Inc. | Treatment of gout |
| US9216179B2 (en) * | 2010-06-15 | 2015-12-22 | Ardea Biosciences, Inc. | Treatment of gout and hyperuricemia |
| WO2011159840A2 (en) | 2010-06-16 | 2011-12-22 | Ardea Biosciences, Inc. | Phenylthioacetate compounds, compositions and methods of use |
| AR081930A1 (es) * | 2010-06-16 | 2012-10-31 | Ardea Biosciences Inc | Compuestos de tioacetato |
| EP2776028B1 (en) * | 2011-11-03 | 2018-10-17 | Ardea Biosciences, Inc. | 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same |
| SG11201804100UA (en) * | 2015-12-08 | 2018-06-28 | Ardea Biosciences Inc | Pharmaceutical composition comprising a potent inhibitor of urat1 |
-
2012
- 2012-11-02 EP EP12784855.4A patent/EP2776028B1/en active Active
- 2012-11-02 CN CN201280065915.XA patent/CN104023723B/zh not_active Expired - Fee Related
- 2012-11-02 US US14/355,480 patent/US10047050B2/en active Active
- 2012-11-02 JP JP2014540154A patent/JP6025853B2/ja not_active Expired - Fee Related
- 2012-11-02 PL PL12784855T patent/PL2776028T3/pl unknown
- 2012-11-02 WO PCT/US2012/063415 patent/WO2013067425A1/en not_active Ceased
- 2012-11-02 CN CN201710322062.8A patent/CN106963761A/zh active Pending
- 2012-11-02 UA UAA201405823A patent/UA114304C2/uk unknown
- 2012-11-02 DK DK12784855.4T patent/DK2776028T3/en active
- 2012-11-02 EA EA201490795A patent/EA026101B1/ru unknown
- 2012-11-02 MX MX2014005343A patent/MX352904B/es active IP Right Grant
- 2012-11-02 CA CA2852490A patent/CA2852490A1/en not_active Abandoned
- 2012-11-02 EP EP18198813.0A patent/EP3501520A1/en not_active Withdrawn
- 2012-11-02 AU AU2012332154A patent/AU2012332154B2/en not_active Ceased
- 2012-11-02 HU HUE12784855A patent/HUE040625T2/hu unknown
- 2012-11-02 BR BR112014010495A patent/BR112014010495A2/pt not_active Application Discontinuation
- 2012-11-02 MY MYPI2014001292A patent/MY180138A/en unknown
- 2012-11-02 SG SG11201402016PA patent/SG11201402016PA/en unknown
- 2012-11-02 ES ES12784855T patent/ES2704233T3/es active Active
- 2012-11-02 KR KR1020147014813A patent/KR101988066B1/ko not_active Expired - Fee Related
-
2014
- 2014-04-13 IL IL232105A patent/IL232105A/en active IP Right Grant
- 2014-04-16 ZA ZA2014/02795A patent/ZA201402795B/en unknown
- 2014-05-02 PH PH12014500997A patent/PH12014500997A1/en unknown
-
2018
- 2018-07-09 US US16/030,410 patent/US10570095B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014532726A5 (enExample) | ||
| JP2013528655A5 (enExample) | ||
| JP6356684B2 (ja) | コルヒチン誘導体の投与による心血管イベントの処置または予防 | |
| JP6097888B2 (ja) | 新規使用 | |
| JP2014532647A5 (enExample) | ||
| JP2013528650A5 (enExample) | ||
| JP5978216B2 (ja) | テオフィリンとフェブキソスタットの併用療法のための方法 | |
| JP2012184234A5 (enExample) | ||
| JP2014532760A5 (enExample) | ||
| JP2013521304A5 (enExample) | ||
| TW201249432A (en) | Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia | |
| DK3027183T3 (en) | SELECTIVE AT2 RECEPTOR AGONISTS FOR USING CACKSY TREATMENT | |
| JP2013087119A5 (enExample) | ||
| RU2014115733A (ru) | Новая соль и медицинское применение | |
| WO2017006254A1 (en) | Drug combination comprising an angiotensin ii receptor antagonist, a neutral endopeptidase inhibitor and a mineralcorticoid receptor antagonist | |
| JP2014532758A5 (enExample) | ||
| CN105358148A (zh) | 用于治疗肾小球疾病的losmapimod | |
| JP2013507383A5 (enExample) | ||
| EP2568982B1 (en) | Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof | |
| EP4360631A1 (en) | Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid | |
| JP2022541482A (ja) | ベリヌラドを含む用量ダンピング耐性医薬組成物 | |
| TWI901895B (zh) | 一種包含１－（３－氰基－１－異丙基－吲哚－５－基）吡唑－４－甲酸的醫藥組成物 | |
| US20240415814A1 (en) | Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid | |
| JP2016505628A5 (enExample) | ||
| WO2005053687A1 (en) | Combination of organic compounds |